К вопросу о роли дистанционной стереотаксической абляционной радиотерапии тела при олигометастатической болезни. Часть V. Дети и подростки

Автор: Паньшин Г.А.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзор

Статья в выпуске: 1 т.24, 2024 года.

Бесплатный доступ

Педиатрический рак с синхронным метастазированием представляет собой редкую клиническую ситуацию. Тем не менее научные общества детской онкологии прилагают значительные усилия, чтобы предложить исследования или консенсус в отношении специального лечения при данной клинической ситуации. В настоящее время появляется все больше проспективных данных, описывающих олигометастатический фенотип у взрослых, у которых местная противоопухолевая терапия, в том числе и радиотерапия, направленная на очаги метастазирование, способствует улучшению результатов специального лечения. Относительная нехватка данных о детях и подростках с олигометастатической болезнью создает проблемы при выборе адекватной тактики специального лечения у онкопедиатрических больных. В данной статье, являющейся заключительной в серии статей, опубликованных за прошедший год в журнале «Вестник РНЦРР» (5 статей) и посвященных роли дистанционной стереотаксической абляционной радиотерапии тела при олигометастатической болезни, приводятся краткие данные по этому вопросу, относящиеся не к взрослому контингенту больных, а к детям и подросткам.

Еще

Олигометастатическая болезнь у детей, дистанционная стереотаксическая абляционная радиотерапия тела, будущие направления

Короткий адрес: https://sciup.org/149145026

IDR: 149145026

Список литературы К вопросу о роли дистанционной стереотаксической абляционной радиотерапии тела при олигометастатической болезни. Часть V. Дети и подростки

Bloom HJ, Wallace EN, Henk JM. The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med. 1969 Jan;105(1):43-62. doi: 10.2214/ajr.105.1.43.
Hirsch JF, Renier D, Czernichow P, Benveniste L, Pierre-Kahn A. Medulloblastoma in childhood. Survival and functional results. Acta Neurochir (Wien). 1979;48(1-2):1-15. doi: 10.1007/BF01406016.
van Eys J, Cangir A, Coody D, Smith B. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol. 1985;3(3):237-243. doi: 10.1007/BF00165184.
Horowitz ME, Mulhern RK, Kun LE, Kovnar E, Sanford RA, Simmons J, et al. Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment. Cancer. 1988 Feb 1;61(3):428-434. doi: 10.1002/1097-0142(19880201)61:3<428::aid-cncr2820610304-3.0.co;2-a.
Packer RJ, Pfister S, Bouffet E, Avery R, Bandopadhayay P, Bornhorst M, et al. Pediatric low-grade gliomas: implications of the biologic era. Neuro Oncol. 2017 Jun 1;19(6):750-761. doi: 10.1093/neuonc/now209.
Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet. 2013 Jun;45(6):602-612. doi: 10.1038/ng.2611.
Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D, et al. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Lancet Oncol. 2017 Jul;18(7):958-971. doi: 10.1016/S1470-2045(17)30243-7.
Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017 Jul 19;547(7663):311-317. doi: 10.1038/nature22973.
Hayabuchi N. Radiocurable tumors and non-radiocurable tumors. JMAJ. 2004;47:79-83.
Lazarev S, Kushner BH, Wolden SL. Short Hypofractionated Radiation Therapy in Palliation of Pediatric Malignancies: Outcomes and Toxicities. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1457-1464. doi: 10.1016/j.ijrobp.2018.07.2012.
Varma S, Friedman DL, Stavas MJ. The role of radiation therapy in palliative care of children with advanced cancer: Clinical outcomes and patterns of care. Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26359.
Hahn C, Kavanagh B, Bhatnagar A, Jacobson G, Lutz S, Patton C, et al. Choosing wisely: the American Society for Radiation Oncology's top 5 list. Pract Radiat Oncol. 2014 Nov-Dec;4(6):349-355. doi: 10.1016/j.prro.2014.06.003.
Palma DA, Haasbeek CJ, Rodrigues GB, Dahele M, Lock M, Yaremko B, et al. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial. BMC Cancer. 2012 Jul 23;12:305. doi: 10.1186/1471-2407-12-305.
Gomez DR, Blumenschein GR Jr, Lee JJ, Hernandez M, Ye R, Camidge DR, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0.
Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, et al. Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001/jamaoncol.2017.3501.
Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst. 2017 Sep 1;109(9):djx015. doi: 10.1093/jnci/djx015.
Trovo M, Furlan C, Polesel J, Fiorica F, Arcangeli S, Giaj-Levra N, et al. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. Radiother Oncol. 2018 Jan;126(1):177-180. doi: 10.1016/j.radonc.2017.08.032.
Haeusler J, Ranft A, Boelling T, Gosheger G, Braun-Munzinger G, Vieth V, et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer. 2010 Jan 15;116(2):443-450. doi: 10.1002/cncr.24740.
Weinlechner J. Tumoren an der brustwand und deren behnadlung resection der rippeneroffnung der brusthohle und partielle entfernung der lunge. Wien Med Wochenschr 1882;32:589-591.
Pastorino U, Gasparini M, Tavecchio L, Azzarelli A, Mapelli S, Zucchi V, et al. The contribution of salvage surgery to the management of childhood osteosarcoma. J Clin Oncol. 1991 Aug;9(8):1357-1362. doi: 10.1200/JCO.1991.9.8.1357.
Pastorino U. Lung metastasectomy for colorectal cancer. Tumori. 1997 Jan-Feb;83(1 Suppl):S28-30.
Ladenstein R, Pötschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol. 2010 Jul 10;28(20):3284-3291. doi: 10.1200/JCO.2009.22.9864.
Haeusler J, Ranft A, Boelling T, Gosheger G, Braun-Munzinger G, Vieth V, et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES). Cancer. 2010 Jan 15;116(2):443-450. doi: 10.1002/cncr.24740.
Cameron AL, Elze MC, Casanova M, Geoerger B, Gaze MN, Minard-Colin V, et al. European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) and the European Innovative Therapies for Children with Cancer (ITCC) Consortium. The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):968-978. doi: 10.1016/j.ijrobp.2021.06.031.
Chandy E, Taylor H, Gaito S, Wells E, Jones C, Meehan C, et al. Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults. Clin Oncol (R Coll Radiol). 2020 May;32(5):316-326. doi: 10.1016/j.clon.2019.11.005.
Smile TD, Parsai S, Pflederer TM, Murphy ES. Treatment paradigms for oligometastatic pediatric cancers: a narrative review with a focus on radiotherapy approaches. Ann Palliat Med. 2021 May;10(5):6002-6015. doi: 10.21037/apm-20-1023.
Tinkle CL, Singh C, Lloyd S, Guo Y, Li Y, Pappo AS, et al. Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1396-1405. doi: 10.1016/j.ijrobp.2020.11.054.
Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, et al. Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma. Sarcoma. 2014;2014:418270. doi: 10.1155/2014/418270.
Stragliotto CL, Karlsson K, Lax I, Rutkowska E, Bergh J, Strander H, et al. A retrospective study of SBRT of metastases in patients with primary sarcoma. Med Oncol. 2012 Dec;29(5):3431-3439. doi: 10.1007/s12032-012-0256-2.
Kim E, Jeans E, Shinohara ET, Stavas MJ. Stereotactic Body Radiotherapy (SBRT) for Metastatic and Recurrent Soft Tissue and Bone Sarcomas. Int J Radiat Oncol Biol Phys 2017;99:E754. doi: 10.1016/j.ijrobp.2017.06.2415.
Parsay S, Sedor G, Scott JG, Reddy CA, Anderson P, Zahler S, et al. Multicenter SBRT for pediatric, adolescent, and young adult patients with metastatic sarcoma: early results and safety data. Int J Radiat Oncol Biol Phys 2019;105:S186-7. doi: 10.1016/j.ijrobp.2019.06.233.
Deck J, Eastwick G, Sima J, Raymond A, Bogart J, Aridgides P. Efficacy and tolerability of stereotactic body radiotherapy for lung metastases in three patients with pediatric malignancies. Onco Targets Ther. 2019 May 15;12:3723-3727. doi: 10.2147/OTT.S194812.
Chang UK, Cho WI, Lee DH, Kim MS, Cho CK, Lee SY, Jeon DG. Stereotactic radiosurgery for primary and metastatic sarcomas involving the spine. J Neurooncol. 2012 May;107(3):551-557. doi: 10.1007/s11060-011-0777-0.
Bishop AJ, Tao R, Guadagnolo BA, Allen PK, Rebueno NC, Wang XA, et al. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine. 2017 Sep;27(3):303-311. doi: 10.3171/2017.1.SPINE161045.
Parsai S, Juloori A, Angelov L, Scott JG, Krishnaney AA, Udo-Inyang I, et al. Spine radiosurgery in adolescents and young adults: early outcomes and toxicity in patients with metastatic Ewing sarcoma and osteosarcoma. J Neurosurg Spine. 2019 Nov 29:1-8. doi: 10.3171/2019.9.SPINE19377.
Elledge CR, Krasin M, Khan P, Alcorn SR, Hiniker SM, Gibbset IC, et al. A multiinstitutional prospective phase II study of hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of metastatic pediatric bone sarcomas. Int J Radiat Oncol Biol Phys 2019;105:S186. doi: 10.1016/j.ijrobp.2019.06.232.
Chandy E, Taylor H, Gaito S, Wells E, Jones C, Meehan C, et al. Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults. Clin Oncol (R Coll Radiol). 2020 May;32(5):316-326. doi: 10.1016/j.clon.2019.11.005.
Janssens GO, Timmermann B, Laprie A, Mandeville H, Padovani L, Chargari C, et al. The organization of care in pediatric radiotherapy across SIOP Europe affiliated centers: A multicenter survey in the framework of the 'Joint Action on Rare Cancers' project. Radiother Oncol. 2024 Feb;191:110075. doi: 10.1016/j.radonc.2023.110075.
SEER. SEER Cancer Statistics Review 1975–2015; Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, et al. (eds). National Cancer Institute: Bethesda, MD, USA, 2018.
Ferrari A, De Salvo GL, Brennan B, van Noesel MM, De Paoli A, Casanova M, et al. Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). Ann Oncol. 2015 Mar;26(3):567-572. doi: 10.1093/annonc/mdu562.
Ferrari A, De Salvo GL, Brennan B, van Noesel MM, De Paoli A, Casanova M, et al. Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). Ann Oncol. 2015 Mar;26(3):567-572. doi: 10.1093/annonc/mdu562.
Whelan J, Le Deley MC, Dirksen U, Le Teuff G, Brennan B, Gaspar N, et al. High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. J Clin Oncol. 2018 Sep 6;36(31):JCO2018782516. doi: 10.1200/JCO.2018.78.2516.
Bisogno G, Jenney M, Bergeron C, Gallego Melcón S, Ferrari A, Oberlin O, et al. European paediatric Soft tissue sarcoma Study Group. Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet Oncol. 2018 Aug;19(8):1061-1071. doi: 10.1016/S1470-2045(18)30337-1.
Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K. Biology and treatment of renal tumours in childhood. Eur J Cancer. 2016 Nov;68:179-195. doi: 10.1016/j.ejca.2016.09.005.
Spunt SL, Million L, Chi YY, Anderson J, Tian J, Hibbitts E, et al. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study. Lancet Oncol. 2020 Jan;21(1):145-161. doi: 10.1016/S1470-2045(19)30672-2.
Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K. Biology and treatment of renal tumours in childhood. Eur J Cancer. 2016 Nov;68:179-195. doi: 10.1016/j.ejca.2016.09.005.
Spunt SL, Million L, Chi YY, Anderson J, Tian J, Hibbitts E, et al. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study. Lancet Oncol. 2020 Jan;21(1):145-161. doi: 10.1016/S1470-2045(19)30672-2.
Verschuur A, Van Tinteren H, Graf N, Bergeron C, Sandstedt B, de Kraker J. Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. J Clin Oncol. 2012 Oct 1;30(28):3533-3539. doi: 10.1200/JCO.2011.35.8747.
Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019 May 18;393(10185):2051-2058. doi: 10.1016/S0140-6736(18)32487-5.
Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, et al. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial. J Clin Oncol. 2018 Feb 10;36(5):446-453. doi: 10.1200/JCO.2017.75.4853.
Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. JAMA Oncol. 2020 May 1;6(5):650-659. doi: 10.1001/jamaoncol.2020.0147.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol. 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1.
Paulino AC, Mai WY, Teh BS. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol. 2013 Jun;36(3):283-6. doi: 10.1097/COC.0b013e3182467ede.
Liu AK, Stinauer M, Albano E, Greffe B, Tello T, Maloney K. Local control of metastatic sites with radiation therapy in metastatic Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer. 2011 Jul 15;57(1):169-71. doi: 10.1002/pbc.23063.
Casey DL, Wexler LH, Meyers PA, Magnan H, Chou AJ, Wolden SL. Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer. 2015 Mar;62(3):445-449. doi: 10.1002/pbc.25294.
Casey DL, Pitter KL, Kushner BH, Cheung NV, Modak S, LaQuaglia MP, Wolden SL. Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved? Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1204-1209. doi: 10.1016/j.ijrobp.2018.01.008.
Skamene S, Abish S, Mitchell D, Freeman C. Radiotherapy is Important for Local Control at Primary and Metastatic Sites in Pediatric Rhabdomyosarcoma. Cureus. 2015 Nov 23;7(11):e388. doi: 10.7759/cureus.388.
FaR-RMS: An Overarching Study for Children and Adults with Frontline and Relapsed RhabdoMyoSarcoma—Full Text View—ClinicalTrials.gov. Available online: https://classic.clinicaltrials.gov/ct2/show/NCT04625907 (accessed on 21 February 2024).
Paulino AC, Mai WY, Teh BS. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol. 2013 Jun;36(3):283-286. doi: 10.1097/COC.0b013e3182467ede.
Liu AK, Stinauer M, Albano E, Greffe B, Tello T, Maloney K. Local control of metastatic sites with radiation therapy in metastatic Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer. 2011 Jul 15;57(1):169-171. doi: 10.1002/pbc.23063.
Casey DL, Wexler LH, Meyers PA, Magnan H, Chou AJ, Wolden SL. Radiation for bone metastases in Ewing sarcoma and rhabdomyosarcoma. Pediatr Blood Cancer. 2015 Mar;62(3):445-449. doi: 10.1002/pbc.25294.
Casey DL, Pitter KL, Kushner BH, Cheung NV, Modak S, LaQuaglia MP, Wolden SL. Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved? Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1204-1209. doi: 10.1016/j.ijrobp.2018.01.008.
Skamene S, Abish S, Mitchell D, Freeman C. Radiotherapy is Important for Local Control at Primary and Metastatic Sites in Pediatric Rhabdomyosarcoma. Cureus. 2015 Nov 23;7(11):e388. doi: 10.7759/cureus.388.
Dix DB, Seibel NL, Chi YY, Khanna G, Gratias E, Anderson JR, et al. Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study. J Clin Oncol. 2018 Jun 1;36(16):1564-1570. doi: 10.1200/JCO.2017.77.1931.
Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. JAMA Oncol. 2020 May 1;6(5):650-659. doi: 10.1001/jamaoncol.2020.0147.
Brown JM, Carlson DJ, Brenner DJ. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):254-262. doi: 10.1016/j.ijrobp.2013.07.022.
Alcorn S, Nilsson K, Rao AD, Ladra MM, Ermoian RP, Villar RC, et al. Practice Patterns of Stereotactic Radiotherapy in Pediatrics: Results From an International Pediatric Research Consortium. J Pediatr Hematol Oncol. 2018 Oct;40(7):522-526. doi: 10.1097/MPH.0000000000001290.
Murphy ES, Chao ST, Angelov L, Vogelbaum MA, Barnett G, Jung E, et al. Radiosurgery for Pediatric Brain Tumors. Pediatr Blood Cancer. 2016 Mar;63(3):398-405. doi: 10.1002/pbc.25831.
69. King D, Connolly D, Zaki H, Lee V, Yeomanson D. Successful treatment of metastatic relapse of medulloblastoma in childhood with single session stereotactic radiosurgery: a report of 3 cases. J Pediatr Hematol Oncol. 2014 May;36(4):301-304. doi: 10.1097/MPH.0b013e3182830fd4.
van Dams R, Park HS, Alomari AK, Ricciardi AS, Rao H, McNamara J, et al. Adjuvant hypofractionated partial-brain radiation therapy for pediatric Ewing sarcoma brain metastases: case report. J Neurosurg Pediatr. 2016 Apr;17(4):434-438. doi: 10.3171/2015.8.PEDS15313.
Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, et al. Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma. Sarcoma. 2014;2014:418270. doi: 10.1155/2014/418270.
Deck J, Eastwick G, Sima J, Raymond A, Bogart J, Aridgides P. Efficacy and tolerability of stereotactic body radiotherapy for lung metastases in three patients with pediatric malignancies. Onco Targets Ther. 2019 May 15;12:3723-3727. doi: 10.2147/OTT.S194812.
Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, Craft AW. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol. 2000 Sep;18(17):3108-3114. doi: 10.1200/JCO.2000.18.17.3108.
Oberlin O, Rey A, Lyden E, Bisogno G, Stevens MC, Meyer WH, et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol. 2008 May 10;26(14):2384-2389. doi: 10.1200/JCO.2007.14.7207.
Mazloom A, Louis CU, Nuchtern J, Kim E, Russell H, Allen-Rhoades W, et al. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):858-862. doi: 10.1016/j.ijrobp.2014.07.019.
Indelicato DJ, Merchant T, Laperriere N, Lassen Y, Vennarini S, Wolden S, et al. Consensus Report From the Stockholm Pediatric Proton Therapy Conference. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):387-392. doi: 10.1016/j.ijrobp.2016.06.2446.
Bourhis J, Montay-Gruel P, Gonçalves Jorge P, Bailat C, Petit B, Ollivier J, et al. Clinical translation of FLASH radiotherapy: Why and how? Radiother Oncol. 2019 Oct;139:11-17. doi: 10.1016/j.radonc.2019.04.008.
Björk-Eriksson T, Ask A, Glimelius B. The potential of proton beam radiation for palliation and reirradiation. Acta Oncol. 2005;44(8):918-920. doi: 10.1080/02841860500355967.
Al-Hallaq H, Cao M, Kruse J, Klein E. Cured in a FLASH: Reducing Normal Tissue Toxicities Using Ultra-High-Dose Rates. Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):257-260. doi: 10.1016/j.ijrobp.2019.01.093.
Ntoukas SM, Ritchie T, Awrey S, Hodgson DC, Laperriere N, Yee R, et al. Minimizing General Anesthetic Use in Pediatric Radiation Therapy. Pract Radiat Oncol. 2020 May-Jun;10(3):e159-e165. doi: 10.1016/j.prro.2019.12.001.
Hiniker SM, Bush K, Fowler T, White EC, Rodriguez S, Maxim PG, et al. Initial clinical outcomes of audiovisual-assisted therapeutic ambience in radiation therapy (AVATAR). Pract Radiat Oncol. 2017 Sep-Oct;7(5):311-318. doi: 10.1016/j.prro.2017.01.007.
Widger K, Davies D, Rapoport A, Vadeboncoeur C, Liben S, Sarpal A, et al. Pediatric palliative care in Canada in 2012: a cross-sectional descriptive study. CMAJ Open. 2016 Oct 11;4(4):E562-E568. doi: 10.9778/cmajo.20160054.
Panoff J, Simoneaux RV, Shah N, Scott M, Buchsbaum JC, Johnstone PA, McMullen KP. Radiation therapy at end of life in children. J Palliat Med. 2015 Feb;18(2):167-169. doi: 10.1089/jpm.2014.0219.
Park KR, Lee CG, Tseng YD, Liao JJ, Reddy S, Bruera E, Yennurajalingam S. Palliative radiation therapy in the last 30 days of life: A systematic review. Radiother Oncol. 2017 Nov;125(2):193-199. doi: 10.1016/j.radonc.2017.09.016.
Tinkle CL, Singh C, Lloyd S, Guo Y, Li Y, Pappo AS, et al. Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1396-1405. doi: 10.1016/j.ijrobp.2020.11.054.
Brown LS, Lester RA, Haddock MG, Sarkaria JN, Olivier KR, Arndt CAS, Laack NN. Stereotactic body radiation therapy (SB 10.1016/j.ijrobp.2013.06.185 RT) for bone tumors in children Int J Radiat Oncol Biol Phys. 2013; 87(2 Suppl):S71. doi: 10.1016/j.ijrobp.2013.06.185.
Bourhis J, Montay-Gruel P, Gonçalves Jorge P, Bailat C, Petit B, Ollivier J, et al. Clinical translation of FLASH radiotherapy: Why and how? Radiother Oncol. 2019 Oct;139:11-17. doi: 10.1016/j.radonc.2019.04.008.

Еще

Статья научная